http://sro.sussex.ac.uk/ http://sro.sussex.ac.uk/images/sitelogo.png http://sro.sussex.ac.uk/ Sun, 26 Nov 2023 20:32:58 +0000 Sun, 26 Nov 2023 20:32:58 +0000 en Tue, 07 Dec 2021 09:19:22 +0000 http://sro.sussex.ac.uk/id/eprint/103268/ http://sro.sussex.ac.uk/id/eprint/103268/ Fallowfield, L J, Farewell, D, Jones, H, May, S, Catt, S, Starkings, R and Jenkins, V (2022) IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer. Breast Cancer Research and Treatment. ISSN 0167-6806 Wed, 26 Aug 2020 08:03:44 +0100 http://sro.sussex.ac.uk/id/eprint/93279/ http://sro.sussex.ac.uk/id/eprint/93279/ Shilling, Valerie, Catt, Susan, Jenkins, Valerie and Fallowfield, Lesley (2020) Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing. Breast Cancer Research and Treatment. ISSN 0167-6806 Tue, 04 Aug 2020 08:26:21 +0100 http://sro.sussex.ac.uk/id/eprint/92906/ http://sro.sussex.ac.uk/id/eprint/92906/ Harder, Helena, Shilling, Valerie M, May, Shirley F, Cella, David, Schmid, Peter and Fallowfield, Lesley J (2020) The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer. Breast Cancer Research and Treatment. pp. 1-10. ISSN 0167-6806 Thu, 25 Jun 2020 11:22:18 +0100 http://sro.sussex.ac.uk/id/eprint/92115/ http://sro.sussex.ac.uk/id/eprint/92115/ Starkings, Rachel, Shilling, Valerie, Jenkins, Valerie and Fallowfield, Lesley (2020) A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer. Breast Cancer Research and Treatment. ISSN 0167-6806 Wed, 12 Jun 2019 08:04:41 +0100 http://sro.sussex.ac.uk/id/eprint/84229/ http://sro.sussex.ac.uk/id/eprint/84229/ Fallowfield, L, Solis-Trapala, I, Starkings, R, Catt, S, May, S and Jenkins, V (2019) Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational programme for clinicians. Breast Cancer Research and Treatment. ISSN 0167-6806 Tue, 07 Jul 2015 08:30:01 +0100 http://sro.sussex.ac.uk/id/eprint/55213/ http://sro.sussex.ac.uk/id/eprint/55213/ Zhang, Hua, Angelopoulos, Nicos, Xu, Yichen, Grothey, Arnhild, Nunes, Joao, Stebbing, Justin and Giamas, Georgios (2015) Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer. Breast Cancer Research and Treatment, 151 (3). pp. 555-568. ISSN 0167-6806 Tue, 07 Jul 2015 07:44:01 +0100 http://sro.sussex.ac.uk/id/eprint/55193/ http://sro.sussex.ac.uk/id/eprint/55193/ Stebbing, Justin, Filipovic, Aleksandra, Ellis, Ian O, Green, Andrew R, D'Silva, Tanya Rapoz, Lenz, Heinz-Josef, Coombes, R Charles, Wang, Tingting, Lee, Soo-Chin and Giamas, Georgios (2012) LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome. Breast Cancer Research and Treatment, 132 (2). pp. 537-544. ISSN 0167-6806 Mon, 08 Dec 2014 14:46:54 +0000 http://sro.sussex.ac.uk/id/eprint/51639/ http://sro.sussex.ac.uk/id/eprint/51639/ Palmieri, C, Cleator, S, Kilburn, L S, Kim, S B, Ahn, S H, Beresford, M, Gong, G, Mansi, J, Mallon, E, Reed, S, Mousa, K, Fallowfield, L, Cheang, M, Morden, J, Page, K, Guttery, D S, Rghebi, B, Primrose, L, Shaw, J A, Thompson, A M, Bliss, J M and Coombes, R C (2014) NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer. Breast Cancer Research and Treatment, 148 (3). pp. 581-590. ISSN 0167-6806 Thu, 26 Apr 2012 11:35:45 +0100 http://sro.sussex.ac.uk/id/eprint/7565/ http://sro.sussex.ac.uk/id/eprint/7565/ Coster, S., Poole, K. and Fallowfield, L. J. (2001) The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Research and Treatment, 68 (3). pp. 273-282. ISSN 0167-6806 Thu, 26 Apr 2012 11:23:30 +0100 http://sro.sussex.ac.uk/id/eprint/7560/ http://sro.sussex.ac.uk/id/eprint/7560/ Fellowes, D., Fallowfield, L. J., Saunders, C. M and Houghton, J. (2001) Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments? Breast Cancer Research and Treatment, 66 (1). pp. 73-81. ISSN 0167-6806 Fri, 26 Aug 2011 15:15:03 +0100 http://sro.sussex.ac.uk/id/eprint/7134/ http://sro.sussex.ac.uk/id/eprint/7134/ Fallowfield, Lesley J. (2008) Treatment decision-making in breast cancer: the patient-doctor relationship. Breast Cancer Research and Treatment, 112. pp. 5-13. ISSN 0167-6806 Thu, 25 Aug 2011 12:39:50 +0100 http://sro.sussex.ac.uk/id/eprint/7117/ http://sro.sussex.ac.uk/id/eprint/7117/ Dixon, J., Renshaw, L, Langridge, C.I, Young, O., McHugh, M., Williams, L., Murray, J.E, Macaskill, E., McCaig, F., Dixon, O.R and Fallowfield, L.J (2011) Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability. Breast Cancer Research and Treatment, 125 (3). pp. 1-9. ISSN 0167-6806 http://sro.sussex.ac.uk/id/eprint/1858/ http://sro.sussex.ac.uk/id/eprint/1858/ Cella, D. and Fallowfield, L. J. (2007) Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Research and Treatment, 107 (2). pp. 167-80. ISSN 0167-6806 http://sro.sussex.ac.uk/id/eprint/678/ http://sro.sussex.ac.uk/id/eprint/678/ Fleissig, A., Fallowfield, L. J., Langridge, C. I., Johnson, L., Newcombe, R. G., Dixon, J. M., Kissin, M. and Mansel, R. E. (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Research and Treatment, 95 (3). pp. 279-93. ISSN 0167-6806 http://sro.sussex.ac.uk/id/eprint/686/ http://sro.sussex.ac.uk/id/eprint/686/ Cella, D., Fallowfield, L. J., Barker, P., Cuzick, J., Locker, G. and Howell, A. (2006) Quality of Life of Postmenopausal Women in the ATAC ("Arimidex", Tamoxifen, Alone or in Combination) Trial after Completion of 5 years' Adjuvant Treatment for Early Breast Cancer. Breast Cancer Research and Treatment, 100 (3). pp. 273-84. ISSN 0167-6806